Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/1640
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | VANDERLOCHT, Joris | - |
dc.contributor.author | BURZYKOWSKI, Tomasz | - |
dc.contributor.author | SOMERS, Veerle | - |
dc.contributor.author | STINISSEN, Piet | - |
dc.contributor.author | HELLINGS, Niels | - |
dc.date.accessioned | 2007-06-15T09:30:10Z | - |
dc.date.available | 2007-06-15T09:30:10Z | - |
dc.date.issued | 2006 | - |
dc.identifier.citation | JOURNAL OF NEUROIMMUNOLOGY, 171(1-2). p. 189-192 | - |
dc.identifier.issn | 0165-5728 | - |
dc.identifier.uri | http://hdl.handle.net/1942/1640 | - |
dc.description.abstract | Neuropoietins such as leukemia inhibitory factor (LIF) have been shown to ameliorate experimental autoimmune encephalomyelitis (EAE) and promote oligodendrocyte survival in vivo. We tested whether two previously described LIF polymorphisms are associated with MS by genotyping these single nucleotide polymorphisms (SNPs) in a group of MS patients (n = 110), rheumatoid arthritis (RA) patients (n = 120) and healthy controls (HC, n = 109). Similar allele and genotype frequencies for both SNPs were found for all study groups. Furthermore, no associations with MS type or HLA-DR2 expression could be found. In summary, no association was found between the studied LIF DNA polymorphisms and the prevalence of MS indicating that these polymorphisms are not involved in determining disease susceptibility. | - |
dc.format.extent | 454122 bytes | - |
dc.format.mimetype | application/pdf | - |
dc.language.iso | en | - |
dc.publisher | Elsevier | - |
dc.subject.other | Multiple sclerosis; Polymorphisms; Leukemia inhibitory factor; Neuroprotection | - |
dc.title | No association of leukemia inhibitory factor (LIF) DNA polymorphisms with multiple sclerosis | - |
dc.type | Journal Contribution | - |
dc.identifier.epage | 192 | - |
dc.identifier.issue | 1-2 | - |
dc.identifier.spage | 189 | - |
dc.identifier.volume | 171 | - |
local.bibliographicCitation.jcat | A1 | - |
local.type.refereed | Refereed | - |
local.type.specified | Article | - |
dc.bibliographicCitation.oldjcat | A1 | - |
dc.identifier.doi | 10.1016/j.jneuroim.2005.09.016 | - |
dc.identifier.isi | 000235114500020 | - |
item.fulltext | With Fulltext | - |
item.accessRights | Open Access | - |
item.validation | ecoom 2007 | - |
item.fullcitation | VANDERLOCHT, Joris; BURZYKOWSKI, Tomasz; SOMERS, Veerle; STINISSEN, Piet & HELLINGS, Niels (2006) No association of leukemia inhibitory factor (LIF) DNA polymorphisms with multiple sclerosis. In: JOURNAL OF NEUROIMMUNOLOGY, 171(1-2). p. 189-192. | - |
item.contributor | VANDERLOCHT, Joris | - |
item.contributor | BURZYKOWSKI, Tomasz | - |
item.contributor | SOMERS, Veerle | - |
item.contributor | STINISSEN, Piet | - |
item.contributor | HELLINGS, Niels | - |
crisitem.journal.issn | 0165-5728 | - |
crisitem.journal.eissn | 1872-8421 | - |
Appears in Collections: | Research publications |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Effects of IFN-β.pdf | Peer-reviewed author version | 443.48 kB | Adobe PDF | View/Open |
SCOPUSTM
Citations
6
checked on Sep 2, 2020
WEB OF SCIENCETM
Citations
5
checked on Sep 11, 2024
Page view(s)
60
checked on Sep 7, 2022
Download(s)
204
checked on Sep 7, 2022
Google ScholarTM
Check
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.